Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 8, 2011, Pages 6676-6682

  Sharma, Praveen ^a   Dube, Brahmanand ^a   Sawant, Krutika ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Blood brain barrier; Cytarabine; In vitro cytotoxicity; Meningeal leukemia; Nanostructured lipid carrier

Indexed keywords

BLOOD-BRAIN BARRIER; CANCER CELLS; CELL LINES; CELL VIABILITY; CONCENTRATION-DEPENDENT; CYTARABINE; CYTOTOXIC EFFECTS; DRUG CONTENT; DRUG ENTRAPMENT; DRUG RESISTANCE; DRUG TRANSPORT; IN-VITRO; LIPID MATRIX; MENINGEAL LEUKEMIA; MOLECULAR DISPERSIONS; NANOSTRUCTURED LIPID CARRIERS; POLYSORBATE 80; RELEASE PATTERN; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE; XRD STUDIES;

BLOOD; CELL CULTURE; DISEASES; DRUG PRODUCTS; EMULSIFICATION;

CYTOTOXICITY;

CYTARABINE; DRUG CARRIER; LIPID; NANOMATERIAL;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; HUMAN; LEUKEMIA; MENINGIOMA; PARTICLE SIZE; POWDER DIFFRACTION; TRANSMISSION ELECTRON MICROSCOPY;

CALORIMETRY, DIFFERENTIAL SCANNING; CYTARABINE; DRUG CARRIERS; HUMANS; LEUKEMIA; LIPIDS; MENINGEAL NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; PARTICLE SIZE; POWDER DIFFRACTION;

EID: 84555205258     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.4235     Document Type: Conference Paper

References (28)

1. S. L. Berg and D. G. Poplack, The Oncologist. 1, 56 (1996).
2. R. L. Capizzi, J. C. White, B. L. Powell, and F. Perrino, Semin. Hematol. 28, 54 (1991).
3. E. Cros, L. Jordheim, C. Dumontet, and C. M. Galmarini, Leuk. Lymphoma. 45, 1123 (2004).
4. S. Nand, H. L. Messmore, R. Patel, S. J. Fisher, and R. I. Fisher, J. Clin. Oncol. 4, 571 (1986).
5. H. L. Wong, R. Bendayan, A. M. Rauth, Y. Li, and X. Wu, Adv. Drug Del. Rev. 59, 491 (2007).
6. Y. Matsumura and H. Maeda, Cancer Res. 6, 193 (1986).
7. M. Muchow, P. Maincent, and R. H. Muller, Drug. Dev. Ind. Pharm. 34, 1394 (2008).
8. X. Lin, X. Li, L. Zheng, L. Yu, Q. Zhang, and W Liu, Colloids Surf., A 311, 106 (2007).
9. E. B. Souto, S. A. Wissing, and C. M. Barbosa, Int. J. Pharm. 278, 71 (2004).
10. W Mehnert and K. Mader, Adv. Drug Deliv. Rev. 47, 165 (2001).
11. L. Jia, D. Zhang, Z. Li, C. Duan, Y Wang, F Feng, F. Wang, Y Liu, and Q. Zhang, Colloids Surf., B 80, 213 (2010).
12. X. Zhang, J. Miao, Y Dai, Y Du, H. Yuan, and F. Hu, Int. J. Pharm. 361, 239 (2008).
13. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi, Adv. Drug Del. Rev. 59, 454 (2007).
14. A. E. Gulyaev, S. E. Gelperina, I. E. Skidan, A. S. Antopov, G. Y Kivman, and J. Kreuter, Pharm. Res. 16, 1564 (1999).
15. T. M. Goppert and R. H. Muller, J. Drug Targeting 13, 179 (2005).
16. B. Dehouck, L. Fenart, M. P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli, J. Cell Biol. 138, 877 (1997).
17. J. Kreuter, Adv. Drug Del. Rev. 47,65 (2001).
18. K. Liu, J. Sun, Y Wang, Y He, K. Gao, and Z. He, Drug Dev. Ind. Pharm. 34, 465 (2008).
19. S. A. Joshi, S. S. Chavhan, and K. K. Sawant, Eur. J. Pharm. Biopharm. 96, 189 (2010).
20. P. Beck, D. Scherer, and J. Kreuter, J. Microencapsulation 7, 491 (1990).
21. W Liu, M. Hu, W. Liu, C. Xue, H. Xu, and X. Yang, Int. J. Pharm. 364, 135 (2008).
22. R. Mulik, V. Kulkarni, and R. S. R. Murthy, Drug Dev. Ind. Pharm. 35, 49 (2009).
23. S. C. Yang, L. F. Lu, J. B. Zhu, and W. L. Bing, J. Controlled Release 59, 299 (1999).
24. R. I. Freshney, Culture of Animal Cells: A Manual of Basic Technique, 4th edn., edited by R. I. Freshney, Wiley-Liss, New York (2000).
25. F. Q. Hu, S. P. Jiang, Y. Z. Du, H. Yuan, Y. Ye, and S. Zeng, Colloids Surf., B 45, 167 (2005).
26. V. Jenning, A. F. Thunemann, and S. H. Gohla, Int. J. Pharm. 199, 167 (2000).
27. X. Li, D. Wang, J. Zhang, and W. Pan, J. Pharm. Pharmacol. 61, 1485 (2009).
28. H. Komatsu, A. Kitajima, and S. Okada, Chem. Pharm. Bull. 43, 1412 (1995).